Matthew Porteus

{{Short description|American professor of medicine}}

{{Infobox scientist

| name = Matthew Porteus

| birth_date =

| birth_place =

| alma_mater = Harvard University
Stanford University

| workplaces = Stanford University
California Institute of Technology
Massachusetts Institute of Technology

| known_for =

| fields =

| awards =

| doctoral_advisor =

| thesis_title = Isolation and Characterization of TES-1/DLX-2: A Novel Homeobox Gene Expressed During Mammalian Forebrain Development

| thesis_url = https://searchworks.stanford.edu/view/5635658

| thesis_year = 1994

| website =

}}

Matthew Hebden Porteus is Sutardja Chuk Professor of Definitive and Curative Medicine at Stanford University.{{cite web |title=Matthew Porteus |url=https://profiles.med.stanford.edu/matthew-porteus |website=Stanford University School of Medicine |access-date=23 June 2021}} In 2003, as a postdoctoral fellow in David Baltimore's lab at the California Institute of Technology, Porteus was the first to demonstrate precise gene editing in human cells using chimeric nucleases.{{cite journal | vauthors = Porteus MH, Baltimore D | title = Chimeric nucleases stimulate gene targeting in human cells | journal = Science | volume = 300 | issue = 5620 | pages = 763 | date = May 2003 | pmid = 12730593 | doi = 10.1126/science.1078395 | s2cid = 34460337 | url = https://authors.library.caltech.edu/51896/}}

He graduated magna cum laude from Harvard University and completed his MD and PhD at Stanford University.{{cite web |title=Dr. Matthew Porteus |url=http://www.crisprtx.com/about-us/leadership/dr-matthew-porteus |website=CRISPR Therapeutics |access-date=23 June 2021}} For his post-doctoral work he trained with David Baltimore at MIT and Caltech. He is a scientific founder of CRISPR Therapeutics and an academic founder of Graphite Bio.{{cite web |title=There Are Now Two Pushes to Treat Sickle Cell Disease With CRISPR |url=https://crisprmedicinenews.com/news/there-are-now-two-pushes-to-treat-sickle-cell-disease-with-crispr/ |website=CRISPR Medicine News |access-date=26 June 2021}}{{cite web |title=About Us: Academic Founders |url=https://graphitebio.com/about-us/academic-founders/ |website=Graphite Bio |access-date=26 June 2021}}

He has an h-index of 69 according to Google Scholar.{{cite web |title=Matthew Porteus |url=https://scholar.google.com/citations?user=mq_BWmwAAAAJ&hl=en&oi=ao |website=Google Scholar |access-date=28 October 2023}}